751 related articles for article (PubMed ID: 10834863)
21. Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis.
Cunnane G; Fitzgerald O; Beeton C; Cawston TE; Bresnihan B
Arthritis Rheum; 2001 Oct; 44(10):2263-74. PubMed ID: 11665967
[TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
[TBL] [Abstract][Full Text] [Related]
23. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and glycosaminoglycans in synovial fluid from patients with rheumatoid arthritis.
Ishiguro N; Ito T; Miyazaki K; Iwata H
J Rheumatol; 1999 Jan; 26(1):34-40. PubMed ID: 9918237
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: a parallel investigation by semiquantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry.
Keyszer G; Redlich A; Häupl T; Zacher J; Sparmann M; Engethüm U; Gay S; Burmester GR
Arthritis Rheum; 1998 Aug; 41(8):1378-87. PubMed ID: 9704635
[TBL] [Abstract][Full Text] [Related]
25. Expression of matrix metalloproteinase-9 (gelatinase B) in gouty arthritis and stimulation of MMP-9 by urate crystals in macrophages.
Hsieh MS; Ho HC; Chou DT; Pan S; Liang YC; Hsieh TY; Lan JL; Tsai SH
J Cell Biochem; 2003 Jul; 89(4):791-9. PubMed ID: 12858344
[TBL] [Abstract][Full Text] [Related]
26. Implication of MMP-9 and urokinase plasminogen activator (uPA) in the activation of pro-matrix metalloproteinase (MMP)-13.
Kim KS; Lee YA; Choi HM; Yoo MC; Yang HI
Rheumatol Int; 2012 Oct; 32(10):3069-75. PubMed ID: 21913037
[TBL] [Abstract][Full Text] [Related]
27. Levels of rheumatoid factor isotypes, metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in synovial fluid from various arthritides.
Kageyama Y; Miyamoto S; Ozeki T; Hiyohsi M; Suzuki M; Nagano A
Clin Rheumatol; 2000; 19(1):14-20. PubMed ID: 10752493
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis.
Fraser A; Fearon U; Reece R; Emery P; Veale DJ
Arthritis Rheum; 2001 Sep; 44(9):2024-8. PubMed ID: 11592363
[TBL] [Abstract][Full Text] [Related]
29. Expression and functional properties of antibodies to tissue inhibitors of metalloproteinases (TIMPs) in rheumatoid arthritis.
Bokarewa M; Dahlberg L; Tarkowski A
Arthritis Res Ther; 2005; 7(5):R1014-22. PubMed ID: 16207317
[TBL] [Abstract][Full Text] [Related]
30. Expression levels of matrix metalloproteinase (MMP)-9 and its specific inhibitor TIMP-1, in septic and aseptic arthritis of the knee.
Fotopoulos VC; Tzinia A; Tzurbakis M; Kalfakakou V; Levidiotou-Stefanou S; Georgoulis A
Knee Surg Sports Traumatol Arthrosc; 2012 Jun; 20(6):1159-67. PubMed ID: 21946941
[TBL] [Abstract][Full Text] [Related]
31. The increase of parathyroid hormone-related peptide and cytokine levels in synovial fluid of elderly rheumatoid arthritis and osteoarthritis.
Horiuchi T; Yoshida T; Koshihara Y; Sakamoto H; Kanai H; Yamamoto S; Ito H
Endocr J; 1999 Oct; 46(5):643-9. PubMed ID: 10670749
[TBL] [Abstract][Full Text] [Related]
32. Synovial fluid RANKL and matrix metalloproteinase levels in enthesitis related arthritis subtype of juvenile idiopathic arthritis.
Agarwal S; Misra R; Aggarwal A
Rheumatol Int; 2009 Jun; 29(8):907-11. PubMed ID: 19052752
[TBL] [Abstract][Full Text] [Related]
33. Distinct fatty acid signatures in infrapatellar fat pad and synovial fluid of patients with osteoarthritis versus rheumatoid arthritis.
Mustonen AM; Käkelä R; Lehenkari P; Huhtakangas J; Turunen S; Joukainen A; Kääriäinen T; Paakkonen T; Kröger H; Nieminen P
Arthritis Res Ther; 2019 May; 21(1):124. PubMed ID: 31118103
[TBL] [Abstract][Full Text] [Related]
34. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
[TBL] [Abstract][Full Text] [Related]
35. Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases.
Agarwal S; Misra R; Aggarwal A
J Rheumatol; 2008 Mar; 35(3):515-9. PubMed ID: 18203309
[TBL] [Abstract][Full Text] [Related]
36. Intraarticular Matrix Metalloproteinases and Aggrecan Degradation Are Elevated After Articular Fracture.
Haller JM; Swearingen CA; Partridge D; McFadden M; Thirunavukkarasu K; Higgins TF
Clin Orthop Relat Res; 2015 Oct; 473(10):3280-8. PubMed ID: 26162411
[TBL] [Abstract][Full Text] [Related]
37. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis.
Fiedorczyk M; Klimiuk PA; Sierakowski S; Gindzienska-Sieskiewicz E; Chwiecko J
J Rheumatol; 2006 Aug; 33(8):1523-9. PubMed ID: 16881109
[TBL] [Abstract][Full Text] [Related]
38. Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis.
Jain A; Nanchahal J; Troeberg L; Green P; Brennan F
Arthritis Rheum; 2001 Aug; 44(8):1754-60. PubMed ID: 11508425
[TBL] [Abstract][Full Text] [Related]
39. [Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis].
Gotoh H; Yamada H; Yoshihara Y; Kikuchi T; Obata K; Shinmei M
Ryumachi; 1997 Feb; 37(1):3-8. PubMed ID: 9128417
[TBL] [Abstract][Full Text] [Related]
40. Increased levels of thymosin β4 in synovial fluid of patients with rheumatoid arthritis: association of thymosin β4 with other factors that are involved in inflammation and bone erosion in joints.
Choi HM; Lee YA; Yang HI; Yoo MC; Kim KS
Int J Rheum Dis; 2011 Oct; 14(4):320-4. PubMed ID: 22004227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
